Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
